Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Volkswagen Group €2.4bn Investment in Chinese Joint Venture with Horizon Robotics

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Volkswagen Group on €2.4bn investment in China smart vehicle technology joint venture with Horizon Robotics. Volkswagen Group (through its subsidiary CARIAD)...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Shenzhen Mindray Bio-Medical Electronics’ €545 Million Acquisition Of Hytest Invest Oy

Freshfields Bruckhaus Deringer advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on the deal. Shenzhen Mindray Bio-Medical Electronics acquired 100 per cent of the issued and outstanding shares...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Shenzhen Mindray Bio-Medical Electronics’ €545 Million Acquisition Of Hytest Invest Oy

Freshfields Bruckhaus Deringer advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on the deal. Shenzhen Mindray Bio-Medical Electronics acquired 100 per cent of the issued and outstanding shares...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here